![](/img/cover-not-exists.png)
Phase I, pharmacogenomic, drug-interaction study of sorafenib and bevacizumab in combination with paclitaxel in patients with advanced refractory solid tumors
Chiorean, E. Gabriela, Perkins, Susan M., Strother, Robert M., Younger, Anne, Funke, Jennifer M, Shahda, Safi G., Hahn, Noah M., Sandrasegaran, Kumaresan, Jones, David R., Skaar, Todd C., Schneider, BJournal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.mct-20-0277
Date:
August, 2020
File:
PDF, 804 KB
2020